June 4, 2014
WASHINGTON, DC — On Wednesday, June 4, 2014, the U.S. Court of Appeals for the Federal Circuit dismissed for lack of Article III standing an appeal against Finnegan client Wisconsin Alumni Research Foundation (WARF) brought by consumer-advocacy organization Consumer Watchdog (CW). The dismissal preserves the decision of the Patent Trial and Appeal Board (PTAB) that all claims of WARF’s U.S. Patent No. 7,029,913 (the ’913 patent) directed to human embryonic stem cell cultures are patentable.
The appeal arose from an inter partes reexamination filed by CW. Following years of reexamination, the PTAB found the ’913 patent claims patentable over the asserted prior art. CW then appealed to the Federal Circuit, where Finnegan as appellate counsel countered CW’s assertions that the claims were both invalid over the prior art and directed to ineligible subject matter. However, in a case of first impression, the Court agreed with WARF and amici the United States and the U.S. Patent and Trademark Office that CW lacked standing to pursue its appeal. The Federal Circuit concluded that CW’s disagreement with the PTAB did not invade any legal right conferred by the inter partes reexamination statute and that CW had not identified any particularized, concrete interest in the patentability of the ’913 patent as, for example, a competitor, licensee, or stem-cell researcher. Because CW did not identify a particularized, concrete interest in the patentability of the ’913 patent, or any injury in fact flowing from the Board’s decision, the Court dismissed its appeal for lack of standing.
With more than 350 intellectual property lawyers, Finnegan is one of the largest IP law firms in the world. From offices in Atlanta, Boston, Palo Alto, Reston, London, Shanghai, Taipei, Tokyo, and Washington, DC, the firm practices all aspects of patent, trademark, copyright, and trade secret law, including counseling, prosecution, licensing, and litigation. Finnegan also represents clients on IP issues related to international trade, portfolio management, the Internet, e-commerce, government contracts, antitrust, and unfair competition. For additional information on the firm, please visit www.finnegan.com. Follow us on LinkedIn and Twitter.
###
Press Release
October 6, 2026
Commentary
Federal Circuit Revives Whistleblower Complaint Over VA's AI Claims-Processing Tool
September 25, 2026
Award/Ranking
Finnegan Named an IP Litigation Powerhouse in BTI Litigation Outlook 2027
September 24, 2026
Press Release
Finnegan Secures Precedential Pro Bono Federal Circuit Victory for AI Whistleblower
September 23, 2026
Award/Ranking
Finnegan Receives Top Tier Rankings in World Trademark Review’s Inaugural Copyright 1000 2026
September 23, 2026
Commentary
New Thomas Pink Womenswear Lines Strain ‘Pink’ Pact with Victoria’s Secret
September 21, 2026
Commentary
Pepsi's U.S. Trademark Dispute Could Reshape Brand Choices, Lawsuit Strategy, Lawyers Say
September 17, 2026
Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.